Study Evaluating Safety And Tolerability, Solid Tumor

NCT00768469 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

DRUG: Neratinib
DRUG: Paclitaxel

Sponsor

Puma Biotechnology, Inc.